A comprehensive view of Moderna Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Moderna, Inc. Files SEC Form 8-K, Current Report: (Sept. 11, 2023)

EU reportedly in talks with Moderna for a new COVID-19 vaccine supply deal to run until 2026 reports the Financial Times; eight countries have expressed interest in a deal

Moderna CEO assures company to maintain strategic partnership with Lonza despite shutdown of COVID-19 vaccination production at Lonza site in Visp, Switzerland

Study finds Moderna vaccine has lower risk of adverse events compared to Pfizer-BioNTech in older US adults, especially in individuals without frailty; results possibly due to better protection against SARS-CoV-2: Brown University & Providence, RI, VAMC

US pharmacies grapple with vaccine shortages in first week of COVID-19 booster rollout as manufacturers cite shipping delays as an issue; residents express frustration over canceled or rescheduled appointments

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count